A family of drug transporters: the multidrug resistance-associated proteins
Abstract
The human multidrug resistance-associated protein (MRP) family currently has seven members. The ability of several of these membrane proteins to transport a wide range of anticancer drugs out of cells and their presence in many tumors make them prime suspects in unexplained cases of drug resistance, although proof that they contribute to clinical drug resistance is still lacking. Recent studies have begun to clarify the function of the MRP family members. MRPs are organic anion transporters; i.e., they transport anionic drugs, exemplified by methotrexate, and neutral drugs conjugated to acidic ligands, such as glutathione (GSH), glucuronate, or sulfate. However, MRP1, MRP2, and MRP3 can also cause resistance to neutral organic drugs that are not known to be conjugated to acidic ligands by transporting these drugs together with free GSH. MRP1 can even confer resistance to arsenite and MRP2 to cisplatin, again probably by transporting these compounds in complexes with GSH. MRP4 overexpression is associated with high-level resistance to the nucleoside analogues 9-(2-phosphonylmethoxyethyl) adenine and azidothymidine, both of which are used as anti-human immunodeficiency virus drugs. MRPs may, therefore, also have a role in resistance against nucleoside analogues used in cancer chemotherapy. Mice without Mrp1, a high-affinity leukotriene C(4) transporter, have an altered response to inflammatory stimuli but are otherwise healthy and fertile. MRP2 is the major transporter responsible for the secretion of bilirubin glucuronides into bile, and humans without MRP2 develop a mild liver disease known as the Dubin-Johnson syndrome. The physiologic functions of the other MRPs are not known. Whether long-term inhibition of MRPs in humans can be tolerated (assuming that suitable inhibitors will be found) remains to be determined.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Overexpression of drug resistance-associated genes, such as P-gp and Bcl-2, is one of the most consistent alterations in multidrug resistant cells.
“Overexpression of drug resistance-associated genes, such as P-gp and Bcl-2, is one of the most consistent alterations in multidrug resistant cells [131–134].”
From Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities (2018) · cites this paper as [131]
Cites
A JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Lindemann, L., Jaeschke, G., Michalon, A., Vieira, E., Honer, M., Spooren, W., Porter, R., Hartung, T., Kolczewski, S., Büttelmann, B., et al. (1909) · JAMA · doi:10.1001/jama.1909.02550020033007 · Cited by 7,865 · see citing works
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
Juliano, R. L., & Ling, V. W. T. (1976) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(76)90160-7 · Cited by 3,317 · see citing works
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G. (1992) · Science · doi:10.1126/science.1360704 · Cited by 3,037 · see citing works
A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T. A., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,319 · see citing works
Schinkel, A. H., Smit, J., van Tellingen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., van der Valk, M. A., Robanus-Maandag, E. C., Riele, H. T., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90212-7 · Cited by 2,284 · see citing works
Self-citationHorder, & Harnett, W. L. (1941) · BMJ · doi:10.1136/bmj.1.4186.493 · Cited by 1,319 · see citing works
The Sister of P-glycoprotein Represents the Canalicular Bile Salt Export Pump of Mammalian Liver
Gerloff, T., Stieger, B., Hagenbuch, B., Madon, J., Landmann, L., Roth, J., Hofmann, A. F., & Meier, P. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.10046 · Cited by 938 · see citing works
Schinkel, A. H., Mayer, U., Wagenaar, E., Mol, C. A. A. M., van Deemter, L., Smit, J. J. M., van der Valk, M. A., Voordouw, A. C., Spits, H., van Tellingen, O., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4028 · Cited by 937 · see citing works
Self-citationThe Journal of Clinical Investigation
Witkin, E. M. (2016) · Journal of the American Dietetic Association · doi:10.1016/0002-8223(94)92394-9 · Cited by 920 · see citing works
Sparreboom, A., van Asperen, J., Mayer, U., Schinkel, A. H., Smit, J. W., Meijer, D. K. F., Borst, P., Nooijen, W. J., Beijnen, J. H., & van Tellingen, O. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.2031 · Cited by 884 · see citing works
Self-citationKool, M., de Haas, M., Scheffer, G. L., Scheper, R. J., van Eijk, M. J., Juijn, J. A., Baas, F., & Borst, P. (1997) · PubMed · Cited by 882 · see citing works
Self-citationLeier, I., Jedlitschky, G., Buchholz, U., Cole, S. P. C., Deeley, R. G., & KEPPLER, D. O. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)46856-1 · Cited by 854 · see citing works
Miyake, K., Mickley, L. A., Litman, T., Zhan, Z., Robey, R. W., Cristensen, B., Brangi, M., Greenberger, L., Dean, M. C., Fojo, T., et al. (1999) · PubMed · Cited by 819 · see citing works
Congenital Jaundice in Rats with a Mutation in a Multidrug Resistance-Associated Protein Gene
Paulusma, C. C., Bosma, P. J., Zaman, G. J. R., Bakker, C., Otter, M. Y., Scheffer, G. L., Scheper, R. J., Borst, P., & Elferink, R. P. J. O. (1996) · Science · doi:10.1126/science.271.5252.1126 · Cited by 817 · see citing works
Self-citationIversen, L. L. (1971) · Nature New Biology · doi:10.1038/newbio229063c0 · Cited by 812 · see citing works
Allikmets, R., Schriml, L. M., Hutchinson, A. A., Romano-Spica, V., & Dean, M. C. (1998) · PubMed · Cited by 798 · see citing works
König, J., Nies, A. T., Cui, Y., Leier, I., & KEPPLER, D. O. R. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00169-8 · Cited by 786 · see citing works
Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells.
Cole, S. P. C., Sparks, K. E., Fraser, K., Loe, D. W., Grant, C. E., Wilson, G. M., & Deeley, R. G. (1994) · PubMed · Cited by 770 · see citing works
Active outward transport of daunomycin in resistant ehrlich ascites tumor cells
Danø, K. (1973) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(73)90191-0 · Cited by 729 · see citing works
Cui, Y., König, J., Buchholz, U., Spring, H., Leier, I., & KEPPLER, D. O. R. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23190-4 · Cited by 674 · see citing works
The ATP-dependent glutathione S-conjugate export pump
Ishikawa, T. (1992) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(92)90489-v · Cited by 658 · see citing works
The multidrug resistance protein family
Borst, P., Evers, R., Kool, M., & Wijnholds, J. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00167-4 · Cited by 648 · see citing works
Self-citationMRP3, an organic anion transporter able to transport anti-cancer drugs
Kool, M., van der Linden, M., de Haas, M., Scheffer, G. L., de Vree, J. M. L., Smith, A. J., Jansen, G., Peters, G. J., Ponne, N. J., Scheper, R. J., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6914 · Cited by 645 · see citing works
Self-citationBüchler, M. W., König, J., Brom, M., Kartenbeck, J., Spring, H., Horie, T., & KEPPLER, D. O. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.15091 · Cited by 639 · see citing works
Grant, C. E., Valdimarsson, G., Hipfner, D. R., Almquist, K. C., Cole, S. P. C., & Deeley, R. G. (1994) · PubMed · Cited by 627 · see citing works
Evers, R., Kool, M., van Deemter, L., Janssen, H., Calafat, J., Oomen, L. C. J. M., Paulusma, C. C., Elferink, R. P. J. O., Baas, F., Schinkel, A. H., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119886 · Cited by 623 · see citing works
Self-citationMüller, M., Meijer, C., Zaman, G. J., Borst, P., Scheper, R. J., Mulder, N. H., de Vries, E. G., & Jansen, P. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.13033 · Cited by 617 · see citing works
Self-citationMutations in ABCC6 cause pseudoxanthoma elasticum
Bergen, A. A. B., Plomp, A. S., Schuurman, E. J. M., Terry, S. F., Breuning, M. H., Dauwerse, H. G., Swart, J., Kool, M., Soest, S. V., Baas, F., et al. (2000) · Nature Genetics · doi:10.1038/76109 · Cited by 590 · see citing works
Self-citationMRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs
Schuetz, J. D., Connelly, M., Sun, D., Paibir, S. G., Flynn, P. M., Srinivas, R. V., Kumar, A., & Fridland, A. (1999) · Nature Medicine · doi:10.1038/12487 · Cited by 575 · see citing works
BindingDB (2013) · PubMed · doi:10.7270/q2q81fck · Cited by 575 · see citing works
Paulusma, C., Kool, M., Bosma, P., Scheffer, G., Borg, F. T., Scheper, R., Tytgat, G., Borst, P., Baas, F., & Elferink, R. O. O. (1997) · Hepatology · doi:10.1002/hep.510250635 · Cited by 561 · see citing works
Self-citationLoe, D. W., Almquist, K. C., Deeley, R. G., & Cole, S. P. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9675 · Cited by 560 · see citing works
Dai, J., Weinberg, R. S., Waxman, S., & Jing, Y. (1999) · Blood · doi:10.1182/blood.v93.1.268 · Cited by 540 · see citing works
Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum
Saux, O. L., Urbán, Z., Tschuch, C., Csiszár, K., Bacchelli, B., Quaglino, D., Pasquali‐Ronchetti, I., Pope, F. M., Richards, A. J., Terry, S. F., et al. (2000) · Nature Genetics · doi:10.1038/76102 · Cited by 538 · see citing works
Rao, V. V., Dahlheimer, J. L., Bardgett, M. E., Snyder, A. Z., Finch, R. A., Sartorelli, A. C., & Piwnica-Worms, D. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3900 · Cited by 531 · see citing works
König, J., Rost, D., Cui, Y., & KEPPLER, D. O. R. (1999) · Hepatology · doi:10.1002/hep.510290404 · Cited by 503 · see citing works
Zaman, G. J. R., Lankelma, J., van Tellingen, O., Beijnen, J. H., Dekker, H., Paulusma, C. C., Elferink, R. P. J. O., Baas, F., & Borst, P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7690 · Cited by 498 · see citing works
Self-citationWijnholds, J., Mol, C. A. A. M., van Deemter, L., de Haas, M., Scheffer, G. L., Baas, F., Beijnen, J. H., Scheper, R. J., Hatse, S., Clercq, E. D., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120159197 · Cited by 478 · see citing works
Self-citationAntifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2.
Hooijberg, J. H., Broxterman, H. J., Kool, M., Assaraf, Y. G., Peters, G. J., Noordhuis, P., Scheper, R. J., Borst, P., Pinedo, H. M., & Jansen, G. (1999) · PubMed · Cited by 442 · see citing works
Self-citationATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein.
Jedlitschky, G., Leier, I., Buchholz, U., et al. (1994) · PubMed · Cited by 435 · see citing works
Wijnholds, J., Evers, R., van Leusden, M. R., Mol, C. A. A. M., Zaman, G. J. R., Mayer, U., Beijnen, J. H., van der Valk, M., Krimpenfort, P., & Borst, P. (1997) · Nature Medicine · doi:10.1038/nm1197-1275 · Cited by 432 · see citing works
Self-citationStructural, mechanistic and clinical aspects of MRP1
Hipfner, D. R., Deeley, R. G., & Cole, S. P. C. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00168-6 · Cited by 412 · see citing works
P-glycoprotein—A mediator of multidrug resistance in tumour cells
Germann, U. A. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00057-3 · Cited by 407 · see citing works
Kartenbeck, J., Leuschner, U., Mayer, R., & KEPPLER, D. O. R. (1996) · Hepatology · doi:10.1053/jhep.1996.v23.pm0008621134 · Cited by 398 · see citing works
Loe, D. W., Deeley, R. G., & Cole, S. P. C. (1998) · PubMed · Cited by 395 · see citing works
Ringpfeil, F., Lebwohl, M., Christiano, A. M., & Uitto, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100041297 · Cited by 388 · see citing works
Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport
Elferink, R. P. J. O., Meijer, D. K. F., Kuipers, F., Jansen, P. L. M., Groen, A. K., & Groothuis, G. M. M. (1995) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(95)00006-d · Cited by 386 · see citing works
Wijnholds, J., de Lange, E. C. M., Scheffer, G. L., van den Berg, D., Mol, C. A. A. M., van der Valk, M., Schinkel, A. H., Scheper, R. J., Breimer, D. D., & Borst, P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8267 · Cited by 361 · see citing works
Self-citationKool, M., van der Linden, M., de Haas, M., Baas, F., & Borst, P. (1999) · PubMed · Cited by 361 · see citing works
Self-citationAllen, J. D., Brinkhuis, R. F., Wijnholds, J., & Schinkel, A. H. (1999) · PubMed · Cited by 353 · see citing works
Self-citationRosenberg, M. F., Callaghan, R., Ford, R. C., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10685 · Cited by 353 · see citing works
Hirohashi, T., Suzuki, H. I., & Sugiyama, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.21.15181 · Cited by 351 · see citing works
Allikmets, R. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.10.1649 · Cited by 334 · see citing works
Functional Multidrug Resistance Protein (MRP1) Lacking the N-terminal Transmembrane Domain
Bakos, É., Evers, R., Szakács, G., Tusnády, G., Welker, E., Szabó, K., de Haas, M., van Deemter, L., Borst, P., Váradi, A., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.32167 · Cited by 326 · see citing works
Self-citationLankas, G. R., Wise, L. D., Cartwright, M. E., Pippert, T. R., & Umbenhauer, D. R. (1998) · Reproductive Toxicology · doi:10.1016/s0890-6238(98)00027-6 · Cited by 314 · see citing works
Rappa, G., Lorico, A., Flavell, R. A., & Sartorelli, A. C. (1997) · PubMed · Cited by 275 · see citing works
Zhu, X., Shen, Y., Jing, Y., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.9.772 · Cited by 275 · see citing works
Ishikawa, T., Bao, J., YAMANE, Y., Akimaru, K., Frindrich, K., Wright, C. D., & Kuo, M. T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.14981 · Cited by 266 · see citing works
Hirohashi, T., Suzuki, H., Ito, K., Ogawa, K., Kume, K., Shimizu, T., & Sugiyama, Y. (1998) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)13278-6 · Cited by 265 · see citing works
Evers, R., Zaman, G. J. R., van Deemter, L., Jansen, H., Calafat, J., Oomen, L. C. J. M., Elferink, R. P. J. O., Borst, P., & Schinkel, A. H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118535 · Cited by 261 · see citing works
Self-citationRenes, J., de Vries, E. G. E., Nienhuis, E. F., Jansen, P. L. M., & Müller, M. M. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702360 · Cited by 256 · see citing works
Multidrug Resistance in Cancer
Kartner, N., & Ling, V. W. T. (1989) · Scientific American · doi:10.1038/scientificamerican0389-44 · Cited by 251 · see citing works
Koike, K., Kawabe, T., Tanaka, T., Toh, S., Uchiumi, T., Wada, M., Akiyama, S. I., Ono, M., & Kuwano, M. (1997) · PubMed · Cited by 249 · see citing works
Ohga, T., Koike, K., Ono, M., et al. (1996) · PubMed · Cited by 244 · see citing works
Lorico, A., Rappa, G., Finch, R. A., Yang, D. D., Flavell, R. A., & Sartorelli, A. C. (1997) · PubMed · Cited by 241 · see citing works
Versantvoort, C. H. M., Broxterman, H. J., Bagrij, T., Scheper, R. J., & Twentyman, P. R. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.281 · Cited by 207 · see citing works
Ishikawa, T., Wright, C. D., & Ishizuka, H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)62016-8 · Cited by 206 · see citing works
Wijnholds, J., Scheffer, G. L., van der Valk, M., van der Valk, P., Beijnen, J. H., Scheper, R. J., & Borst, P. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.5.797 · Cited by 202 · see citing works
Self-citationMcAleer, M. A., Breen, M. A., White, N. L., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23541 · Cited by 198 · see citing works
Transport properties of the multidrug resistance‐associated protein (MRP) in human tumour cells
Holló, Z., Homolya, L., Hegedűs, T., & Sarkadi, B. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00237-2 · Cited by 195 · see citing works
BindingDB (2013) · PubMed · doi:10.7270/q2571d9z · Cited by 173 · see citing works
Young, L. C., Campling, B. G., Voskoglou-Nomikos, T., Cole, S. P. C., Deeley, R. G., & Gerlach, J. H. (1999) · PubMed · Cited by 168 · see citing works
Gao, M., Loe, D. W., Grant, C. E., Cole, S. P. C., & Deeley, R. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27782 · Cited by 159 · see citing works
MOAT-E (ARA) is a full-length MRP/cMOAT subfamily transporter expressed in kidney and liver
Belinsky, M. G., & Kruh, G. D. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690527 · Cited by 143 · see citing works
Structure of the human MDR3 gene and physical mapping of the human MDR locus.
Lincke, C. R., Smit, J., der Velde-Koerts, T. V., et al. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67788-4 · Cited by 137 · see citing works
Genetic dissection of the function of mammalian P-glycoproteins
Borst, P., & Schinkel, A. H. (1997) · Trends in Genetics · doi:10.1016/s0168-9525(97)01112-8 · Cited by 124 · see citing works
Self-citationKEPPLER, D. O. R., Leier, I., Jedlitschky, G., & König, J. (1998) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(97)00158-0 · Cited by 121 · see citing works
Pharmacologic approaches to reversing multidrug resistance.
Sikic, B. I. (1997) · PubMed · Cited by 117 · see citing works
Structure of the multidrug resistance P-glycoprotein
Higgins, C. F., Callaghan, R., Linton, K. J., et al. (1997) · Seminars in Cancer Biology · doi:10.1006/scbi.1997.0067 · Cited by 116 · see citing works
Double knockout of the MRP gene leads to increased drug sensitivity in vitro.
Lorico, A., Rappa, G., Flavell, R. A., & Sartorelli, A. C. (1996) · PubMed · Cited by 89 · see citing works
Flip-Flop of Doxorubicin across Erythrocyte and Lipid Membranes
Regev, R., & Eytan, G. D. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00326-2 · Cited by 82 · see citing works
Nishino, J.-I., Suzuki, H., Sugiyama, D., Kitazawa, T., Ito, K., Hanano, M., & Sugiyama, Y. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34897-9 · Cited by 78 · see citing works
MRP3, a new ATP-binding cassette protein localized to the canalicular domain of the hepatocyte
Ortiz, D. F., Li, S., Iyer, R., Zhang, X., Novikoff, P. M., & Arias, I. M. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.276.6.g1493 · Cited by 64 · see citing works
Future perspectives for the development of P-glycoprotein modulators
Sandor, V. A., Fojo, T., & Bates, S. E. (1998) · Drug Resistance Updates · doi:10.1016/s1368-7646(98)80039-3 · Cited by 63 · see citing works
Longhurst, T., O’Neill, G. M., Harvie, R. M., & Davey, R. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.545 · Cited by 62 · see citing works
Kuo, M. T., Bao, J., Furuichi, M., et al. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00494-2 · Cited by 57 · see citing works
Rappa, G., Finch, R. A., Sartorelli, A. C., et al. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00074-x · Cited by 55 · see citing works
Wallstab, A., Koester, M., Böhme, M., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690169 · Cited by 50 · see citing works
P-Glycoprotein-Mediated Multidrug Resistance: Experimental and Clinical Strategies for its Reversal
Ford, J. M., Yang, J., & Hait, W. N. (1996) · Cancer treatment and research · doi:10.1007/978-1-4613-1267-3_1 · Cited by 48 · see citing works
Introduction: Multidrug resistant proteins
Borst, P. (1997) · Seminars in Cancer Biology · doi:10.1006/scbi.1997.0072 · Cited by 35 · see citing works
Self-citationRegulation of organic anion transport in the liver.
Roelofsen, H., Müller, M., & Jansen, P. L. M. (1998) · PubMed · Cited by 31 · see citing works
Saxena, M., & Henderson, G. B. (1996) · Biochemical Journal · doi:10.1042/bj3200273 · Cited by 28 · see citing works
O’Neill, G. M., Peters, G., Harvie, R., et al. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.350 · Cited by 22 · see citing works
Kuss, B. J., O’Neill, G. M., Eyre, H. J., et al. (1998) · Genomics · doi:10.1006/geno.1998.5349 · Cited by 21 · see citing works
Henderson, G. B., Hughes, T. R., & Saxena, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36844-8 · Cited by 16 · see citing works
Cole, S. P. C. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.10.888 · Cited by 4 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536 · see citing works
Targeting multidrug resistance in cancer
Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609 · see citing works
Cisplatin: mode of cytotoxic action and molecular basis of resistance
Siddik, Z. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206933 · Cited by 3,335 · see citing works
Molecular mechanisms of cisplatin resistance
Galluzzi, L., Senovilla, L., Vitale, I., Michels, J., Martins, I., Kepp, O., Castedo, M., & Kroemer, G. (2012) · Oncogene · doi:10.1038/onc.2011.384 · Cited by 2,760 · see citing works
The human ATP-binding cassette (ABC) transporter superfamily
Dean, M., Hamon, Y., & Chimini, G. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31588-1 · Cited by 1,302 · see citing works
Deeley, R. G., Westlake, C., & Cole, S. P. C. (2006) · Physiological Reviews · doi:10.1152/physrev.00035.2005 · Cited by 761 · see citing works
Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities
Li, L., Hu, S., & Chen, X. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.04.031 · Cited by 415 · see citing works
Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters
Leslie, E. (2001) · Toxicology · doi:10.1016/s0300-483x(01)00454-1 · Cited by 376 · see citing works
Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases
Chen, Z., & Tiwari, A. K. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08235.x · Cited by 274 · see citing works
Mutant p53 Cooperates with ETS and Selectively Up-regulates Human MDR1 Not MRP1
Sampath, J., Sun, D., Kidd, V. J., Grenet, J., Gandhi, A., Shapiro, L. H., Wang, Q., Zambetti, G. P., & Schuetz, J. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103429200 · Cited by 244 · see citing works
Nanoscale drug delivery systems and the blood–brain barrier
Khalin, I., Alyautdin, R., Ismail, N. M., Haron, M. H., & Kuznetsov, D. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s52236 · Cited by 204 · see citing works
Dysfunction of ABC transporters at the blood-brain barrier: Role in neurological disorders
Gil-Martins, E., Barbosa, D. J., Silva, V., Remião, F., & Silva, R. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107554 · Cited by 152 · see citing works
Steroid hormone biotransformation and xenobiotic induction of hepatic steroid metabolizing enzymes
You, L. (2004) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2004.01.006 · Cited by 145 · see citing works
Duesberg, P., Stindl, R., & Hehlmann, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201398998 · Cited by 106 · see citing works
Hemauer, S. J., Patrikeeva, S. L., Nanovskaya, T. N., Hankins, G. D. V., & Ahmed, M. S. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.01.035 · Cited by 103 · see citing works
Hamdoun, A. M., Cherr, G. N., Roepke, T. A., & Epel, D. (2004) · Developmental Biology · doi:10.1016/j.ydbio.2004.09.013 · Cited by 91 · see citing works
Ku, J.-L., Shin, Y.-K., Kim, D.-W., Kim, K.-H., Choi, J.-S., Hong, S.-H., Jeon, Y.-K., Kim, S.-H., Kim, H.-S., Park, J.-H., et al. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq043 · Cited by 52 · see citing works
- Authors
- Borst, P., Evers, R., Kool, M., & Wijnholds, J.
- Affiliations
- The Netherlands Cancer Institute (NL)
- Corresponding author
- Borst, P.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-08-16
- Volume
- 92
- Issue
- 16
- Pages
- 1295-1302
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2110790042
- Cited by
- 1,751
- References
- 96
- Citations by year
- 2026: 9 · 2025: 26 · 2024: 24 · 2023: 38 · 2022: 38 · 2021: 52 · 2020: 44 · 2019: 32 · 2018: 48 · 2017: 58 · 2016: 66 · 2015: 63 · 2014: 81 · 2013: 74 · 2012: 57
- FWCI
- 11.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JNCI Journal of the National Cancer Institute (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Antibiotic Resistance in Bacteria
- Keywords
- multidrug resistance-associated protein, MRP1, MRP2, MRP3, MRP4, organic anion transporters, drug resistance, anticancer drug efflux, glutathione conjugates, methotrexate, cisplatin, arsenite, nucleoside analogues, HIV drugs, Dubin-Johnson syndrome, bile secretion
- MeSH terms
- Animals, Humans, Neoplasm Proteins, Neoplasms, Up-Regulation, Gene Expression Regulation, Neoplastic, Drug Resistance, Multiple, ATP-Binding Cassette Transporters, Drug Resistance, Neoplasm, ATP-Binding Cassette, Sub-Family C Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review